2018
DOI: 10.1016/j.nrleng.2016.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Brain microbleeds: Epidemiology and clinical implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(14 citation statements)
references
References 70 publications
0
12
0
Order By: Relevance
“…Brain microbleeds are often associated with the aging process, AD, and hemorrhagic or ischemic strokes. 53 The data evaluated together for MCI (►Table 1), VD (►Table 2), and AD (►Table 3) indicate an increase in homocysteine levels, which is a marker of impairment in vitamin B12 and folate metabolism but also strongly correlated with endothelial damage. 54,55 Folate and vitamin B12 deficiencies promote an elevated level of homocysteine, possibly leading to endothelial and neuronal injury.…”
Section: Discussionmentioning
confidence: 99%
“…Brain microbleeds are often associated with the aging process, AD, and hemorrhagic or ischemic strokes. 53 The data evaluated together for MCI (►Table 1), VD (►Table 2), and AD (►Table 3) indicate an increase in homocysteine levels, which is a marker of impairment in vitamin B12 and folate metabolism but also strongly correlated with endothelial damage. 54,55 Folate and vitamin B12 deficiencies promote an elevated level of homocysteine, possibly leading to endothelial and neuronal injury.…”
Section: Discussionmentioning
confidence: 99%
“…Cerebral microbleeds (CMBs), a typical imaging marker of CSVD (Wardlaw et al, 2013 ), have an incidence of 5–35% in individuals aged older than 45 years (Haller et al, 2018 ). The proportion of CMBs is 16–45% and up to 86% in patients with cognitive impairment and vascular dementia, respectively (Boyano et al, 2018 ). A high CMB count might increase the risk of cognitive decline, even dementia, and the location of CMBs might involve the different impaired cognitive domains (Akoudad et al, 2016 ; Ding et al, 2017 ; Li et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…
CMBs are a radiological biomarker of cerebral small vessel disease. They are seen on blood-sensitive MRI sequences such as T2*-weighted gradient-recalled echo (T2*-GRE) or susceptibility-weighted imaging (SWI) 1,2,3,4,5,6 . They are small (usually <5 mm in diameter), rounded or oval lesions of low signal intensity in the brain parenchyma 1,2,3,4,7,8 .
…”
mentioning
confidence: 99%
“…They are seen on blood-sensitive MRI sequences such as T2*-weighted gradient-recalled echo (T2*-GRE) or susceptibility-weighted imaging (SWI) 1,2,3,4,5,6 . They are small (usually <5 mm in diameter), rounded or oval lesions of low signal intensity in the brain parenchyma 1,2,3,4,7,8 . CMBs represent haemosiderin deposits contained within macrophages in the microvascular perivascular spaces on histopathological examinations 1,2,3,4,9 , and develop as a result of leakage of red blood cells secondary to rupture of the walls of small arteries, arterioles or capillaries 1,2,10 .…”
mentioning
confidence: 99%
See 1 more Smart Citation